Abstract
Here we report a case that presented with sudden onset of neurological symptoms and was treated with ganciclovir. Polymerase chain reaction analysis for human herpes virus-6 (HHV-6) from his cerebrospinal fluid was later found to be positive. He subsequently recovered with minimal residual neurological symptoms. Encephalitis secondary to this virus may be more common than previously thought in patients undergoing bone marrow transplantation. This condition should be considered in the differential diagnosis of sudden onset neurological symptoms after bone marrow transplantation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mookerjee, B., Vogelsang, G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplant 20, 905–906 (1997). https://doi.org/10.1038/sj.bmt.1700988
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1700988
- Springer Nature Limited
Keywords
This article is cited by
-
Herpes simplex encephalitis following spinal ependymoma resection: case report and literature review
Journal of Neuro-Oncology (2011)
-
Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients
Bone Marrow Transplantation (2007)
-
Human herpes virus-6 encephalitis in a paediatric bone marrow recipient: successful treatment with pharmacokinetic monitoring and high doses of ganciclovir
Bone Marrow Transplantation (2006)
-
Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation
Bone Marrow Transplantation (2002)
-
Human herpesvirus 6 and human herpesvirus 7: Emerging pathogens in transplant patients
International Journal of Hematology (2002)